High-grade gliomas represent the most common group of
infiltrative
primary brain tumors in adults associated with high invasiveness,
agressivity, and resistance to therapy, which highlights the need
to develop potent drugs with novel mechanisms of action. The aim of
this study is to reveal changes in proteome profiles under stressful
conditions to identify prognostic biomarkers and altered apoptogenic
pathways involved in the anticancer action of human isocitrate dehydrogenase
(IDH) mutant high-grade gliomas. Our protocol consists first of a
3D in vitro developing neurospheroid model and then
treatment by a pesticide mixture at relevant concentrations. Furthermore,
we adopted an untargeted proteomic-based approach with high-resolution
mass spectrometry for a comparative analysis of the differentially
expressed proteins between treated and nontreated spheroids. Our analysis
revealed that the majority of altered proteins were key members in
glioma pathogenesis, implicated in the cellular metabolism, biological
regulation, binding, and catalytic and structural activity and linked
to many cascading regulatory pathways. Our finding revealed that grade-IV
astrocytomas promote the downstream of the mitogen-activated-protein-kinases/extracellular-signal-regulated
kinase (MAPK1/ERK2) pathway involving massive calcium influx. The
gonadotrophin-releasing-hormone signaling enhances MAKP activity and
may serve as a negative feedback compensating regulator. Thus, our
study can pave the way for effective new therapeutic and diagnostic
strategies to improve the overall survival.